João Paulo Capela
banner
jpcapela.bsky.social
João Paulo Capela
@jpcapela.bsky.social
Farmacêutico, PhD em Toxicologia, Professor Uni. Farmacologia e Toxicologia 🧪🔬🧠🇵🇹

Pharmacist, PhD in Toxicology, Uni. Professor of Pharmacology and Toxicology 🧪🔬🧠 🇪🇺

Views my own!

https://scholar.google.pt/citations?user=xlO_SBQAAAAJ&hl=pt-PT
July 29, 2025 at 9:53 PM
I don’t think AI can help in reviewing, and more importantly manny journals do not allow it for some very good reasons. I rejected a paper recently because it was found that it was clearly AI written! However, using AI to fine tune English should be fine.

#PharmSky
#ToxSky
#MedSky
#NeuroSky
🧪
March 6, 2025 at 1:42 PM
Clinical trials back then agreed in a minor, but statistically significant effect. The problems are the adverse events like cardiovascular and potential abuse.
January 23, 2025 at 11:39 AM
More one good news for science 🧪
January 16, 2025 at 12:50 PM
That brings me back good memories, when I stayed until late hours I the lab✌️🧠🧪
December 2, 2024 at 9:52 PM
MDMA could be helpful in PSTD or other brain disorders. There should be clinical trials not only showing effectiveness but also safety, not only in the short but also in the long term. Caution is required due to the potential neurotoxicity and hepatotoxic actions of MDMA and it’s metabolites. 🧪
November 27, 2024 at 10:14 PM
Mais uma investigadora de renome a dizer o óbvio! O financiamento da FCT no próxima OE vai baixar e seguramente no ano seguinte será igual. Se já estávamos com um nível baixo de financiamento da FCT, vamos ficar ainda pior!
November 23, 2024 at 4:59 PM